News

The Manila Times2h
Harbour BioMed to Present Phase II Data of HBM4003 and Tislelizumab Combination in MSS Metastatic Colorectal Cancer at ESMO 2025
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 30, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global ...
Thyroid Cancer Pipeline Outlook Report 2025: Key 50+ Companies And Breakthrough Therapies Shaping The Future Landscape
DelveInsight's,“ Thyroid Cancer Pipeline Insight 2025” report provides comprehensive insights about 50+ companies and 51+ ...
SB43154 drug used in cancer research shows promise against COVID-19 in preclinical studies: Scientists
Indian scientists discover cancer drug SB431542 effectively fights COVID-19, showing potential to prevent virus resistance in ...
TMCnet21h
Innate Pharma Announces Its Participation in the BTIG Virtual Biotechnology Conference
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (" Innate " or the " Company ") today announced that the company's CEO Jonathan Dickinson and COO Yannis Morel will participate in the BTIG Virtual ...